Briser les tabous Connaître votre réalité Vous informer sur la normalité du vieillissement Avoir du plaisir, tout en discutant Thèmes Le vieillissement normal L’âgisme L’isolement
. Disparités régionales Primes d'éloignement et d'isolement Primes de rétention Sorties
support in order to break feelings of isolation while receiving care. To contact Mr. Steve Guimond, call 418-932-0095 or email him at: navigator@qchfoundation.org (call him before you leave
'accès aux activités socioprofessionnelles ou encore à l'isolement vécu. De tels bouleversements peuvent avoir un grand impact chez ces personnes dont le quotidien repose souvent sur une organisation
Baie-Comeau, April 12, 2022 - The Centre intégré de santé et de services sociaux (CISSS) de la Côte‑Nord informs the population that the second booster dose of the COVID-19 vaccine is now available to people aged 55 and over in remote and isolated communities as well as in Indigenous communities. Press release
A telephone line is available for those who have questions about the road control points for travel between regions: 1 833 390-0625 (Fermont: 418 287-3280, ext. 712200). This line is available from 8:00 a.m. to 8:00 p.m., 7 days a week. Its purpose is not to authorize travel, but to provide information on the requirements of the Order in Council. It can also be used to learn more about the isolation requirements, notably in Minganie and on the Lower North Shore. You are invited to call this line instead of calling the SQ.
, it is important to ask for help: Concentration problems Sleep problems Tendency for social isolation Reduced interest in fun activities Increased alcohol or drug use Irritable mood or sadness
'offrir ses services, mais il en a même développé de nouveaux. La popote roulante, le service d'épicerie en ligne et les appels de réconfort pour briser l'isolement ne sont que quelques-unes des initiatives qui
The Centre intégré de santé et de services sociaux (CISSS) de la Côte-Nord wishes to inform the population of certain limitations regarding visits to patients in isolation that will beeffective on March 9th, 2020 and will be active for an unspecified period of time. Press release
